Girentuximab, CAS 916138-87-9

Product Description: Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC)[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Chamie K, et al. Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial. JAMA Oncol. 2017;3(7):913-920.

CAS Number: 916138-87-9

Molecular Weight: N/A

Compound Purity: 99.90

Research Area: Cancer

Solubility: H2O

Target: Carbonic Anhydrase

• SKU: MEXHY-P99023-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99023-10
• Green Labware: No
• Package Unit: 10 mg
• Quantity Unit: STK